InsiderClue
Insiders · Profile

Stalfort John A III

Director at Verrica Pharmaceuticals · Director at Taysha Gene Therapies · Director at Acumen Pharmaceuticals. Filing since 7 Jan 2019. CIK 0001709418

VRCA Verrica Pharmaceuticals Inc. Director · 5 trades TSHA Taysha Gene Therapies, Inc. Director · 2 trades ABOS Acumen Pharmaceuticals, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
VRCA Verrica Pharmaceuticals Inc.
22 Nov 2024
Director
Bought
1,123,595
no price
160%
TSHA Taysha Gene Therapies, Inc.
16 Aug 2023
Director
Bought
388,889
$350.00K
78.5%
TSHA Taysha Gene Therapies, Inc.
16 Aug 2023
Director
Bought
388,889
$350.00K
63.7%
VRCA Verrica Pharmaceuticals Inc.
5 Jul 2022
Director
Bought
238,095
$500.00K
51.5%
ABOS Acumen Pharmaceuticals, Inc.
6 Jul 2021
Director
Bought
35,000
$560.00K
25.5%
VRCA Verrica Pharmaceuticals Inc.
14 Aug 2020
Director
Bought
15,700
$100.17K
3.5%
VRCA Verrica Pharmaceuticals Inc.
13 Aug 2020
Director
Bought
15,550
$100.30K
3.6%
VRCA Verrica Pharmaceuticals Inc.
7 Jan 2019
Director
Bought
9,221
$96.39K
2.2%
8 decisions on file.